BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20799911)

  • 1. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.
    Nielsen HJ; Brünner N; Jorgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Stieber P; Blankenstein MA; Davis G; Dowell BL; Christensen IJ; ;
    Scand J Gastroenterol; 2011 Jan; 46(1):60-9. PubMed ID: 20799911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.
    Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D
    Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.
    Nielsen HJ; Christensen IJ; Brünner N
    Scand J Gastroenterol; 2010; 45(2):200-7. PubMed ID: 20095885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study.
    Birgisson H; Nielsen HJ; Christensen IJ; Glimelius B; Brünner N
    Eur J Cancer; 2010 Dec; 46(18):3323-31. PubMed ID: 20619633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer.
    Holten-Andersen MN; Nielsen HJ; Sørensen S; Jensen V; Brünner N; Christensen IJ
    Eur J Cancer; 2006 Aug; 42(12):1889-96. PubMed ID: 16809030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
    Frederiksen C; Lomholt AF; Davis GJ; Dowell BL; Blankenstein MA; Christensen IJ; Brünner N; Nielsen HJ
    Anticancer Res; 2009 Jan; 29(1):75-81. PubMed ID: 19331135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy.
    Piper TB; Nielsen HJ; Christensen IJ
    Tumour Biol; 2022; 44(1):1-16. PubMed ID: 35180141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective study.
    Holten-Andersen L; Christensen IJ; Jensen SB; Reibel J; Laurberg S; Nauntofte B; Brünner N; Nielsen HJ
    Scand J Gastroenterol; 2012 Oct; 47(10):1234-41. PubMed ID: 22871105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.
    Holten-Andersen MN; Fenger C; Nielsen HJ; Rasmussen AS; Christensen IJ; Brünner N; Kronborg O
    Eur J Cancer; 2004 Sep; 40(14):2159-64. PubMed ID: 15341992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma TIMP-1 and serum CEA levels during combination chemotherapy for metastatic colorectal cancer are significantly associated with poor outcome.
    Aldulaymi B; Byström P; Berglund A; Christensen IJ; Brünner N; Nielsen HJ; Glimelius B
    Oncology; 2010; 79(1-2):144-9. PubMed ID: 21150229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
    El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
    Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer.
    Aldulaymi B; Christensen IJ; Sölétormos G; Jess P; Nielsen SE; Brünner N; Nielsen HJ
    Anticancer Res; 2010 Jan; 30(1):233-7. PubMed ID: 20150641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.
    Holten-Andersen MN; Christensen IJ; Nielsen HJ; Stephens RW; Jensen V; Nielsen OH; Sørensen S; Overgaard J; Lilja H; Harris A; Murphy G; Brünner N
    Clin Cancer Res; 2002 Jan; 8(1):156-64. PubMed ID: 11801553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.
    Ferroni P; Roselli M; Spila A; D'Alessandro R; Portarena I; Mariotti S; Palmirotta R; Buonomo O; Petrella G; Guadagni F
    Cancer; 2010 Jun; 116(12):2913-21. PubMed ID: 20336782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
    Holten-Andersen MN; Stephens RW; Nielsen HJ; Murphy G; Christensen IJ; Stetler-Stevenson W; Brünner N
    Clin Cancer Res; 2000 Nov; 6(11):4292-9. PubMed ID: 11106246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer.
    Aldulaymi B; Christensen IJ; Sölétormos G; Jess P; Nielsen SE; Laurberg S; Brünner N; Nielsen HJ
    Anticancer Res; 2010 Nov; 30(11):4755-9. PubMed ID: 21115936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.